# Pulmonx

Type: Company (LUNG)

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/pulmonx
Canonical HTML page: https://gethealthbrief.com/entity/pulmonx

## Recent coverage (1 stories)

### GLP-1 Surge Drives Stevanato Growth as MedTech Sector Pivots to Efficiency
2026-03-05 00:14:04 · Sentiment: Positive · Impact: 6/10 · Sources: 14

Stevanato Group reported robust 2025 results fueled by a 50% surge in GLP-1 related revenue, while medical device maker Pulmonx initiated aggressive cost-cutting measures following a U.S. revenue decline. The divergence highlights a shifting healthcare landscape where specialized biopharma supply chains are outperforming traditional niche medical devices.
Full story: https://gethealthbrief.com/story/stevanato-pulmonx-earnings-glp1-trends-2025

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.